Designing Antibiotics with Inherent Resistance to Efflux as a Strategy to Revive Discovery against Multidrug-Resistant Pathogens
Open Access
- 29 May 2026
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (11) , 13071-13098
Abstract
We report a novel Efflux Resistance Breaker (ERB) strategy for designing antibiotics intrinsically resistant to efflux, using fluoroquinolones as a model class. ERB-modified fluoroquinolones showed enhanced intracellular accumulation and markedly improved antibacterial activity, with up to 512-fold reduction in MIC (MIC90 0.03–2 μg/mL) across multidrug-resistant bacteria. Lead compounds KSN-L22 (46) and BL-7 (50) demonstrated potent activity against MRSA, Streptococcus pneumoniae (including MDR and PRSP), Enterococcus faecalis and E. faecium (VanA, VanB and VanD), as well as Acinetobacter baumannii and Escherichia coli. The compounds inhibited both wild-type and S84L mutant DNA gyrase (IC50 ∼ 3.8 μg/mL) and achieved a > 4-log bacterial load reduction in a murine thigh infection model at oral doses of 50 mg/kg. Favorable oral and intravenous PK/PD profiles, absence of toxicity at 1200 mg/kg/day, and no hERG, CYP450, or off-target liabilities were observed. ERB technology provides a promising strategy for designing antibiotics that are intrinsically less susceptible to efflux.Keywords
All Related Versions
Funding Information
- Medical Research Council (MR/W018594/1)
- Kingâ??s Commercialisation Institute (JGA9300)
- UK Health Security Agency (113361)
- Biotechnology and Biological Sciences Research Council (BB/M015033/1)
This publication has 65 references indexed in Scilit:
- Whole Genome Sequencing of Staphylococcus aureus SA-1199B Reveals Previously Unreported MutationsInternational Journal of Antimicrobial Agents, 2021
- What Is Old Is New Again: Delafloxacin, a Modern FluoroquinolonePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2017
- Improvements to the APBS biomolecular solvation software suiteProtein Science, 2017
- Synthesis and antibacterial activity of novel fluoroquinolone analogsMedicinal Chemistry Research, 2014
- Design, synthesis, and evaluation of novel fluoroquinolone–flavonoid hybrids as potent antibiotics against drug-resistant microorganismsEuropean Journal of Medicinal Chemistry, 2014
- Enhanced bacterial efflux system is the first step to the development of metronidazole resistance in Helicobacter pyloriBiochemical and Biophysical Research Communications, 2011
- Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking groupBioorganic & Medicinal Chemistry, 2009
- Synthesis and evaluation of fluoroquinolone derivatives as substrate-based inhibitors of bacterial efflux pumpsEuropean Journal of Medicinal Chemistry, 2008
- Practical applications and feasibility of efflux pump inhibitors in the clinic—A vision for applied useBiochemical Pharmacology, 2006
- Temperature dependence of TIP3P, SPC, and TIP4P water from NPT Monte Carlo simulations: Seeking temperatures of maximum densityJournal of Computational Chemistry, 1998